Alnylam to webcast presentation at goldman sachs 44th annual global healthcare conference

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will present a company overview at the goldman sachs 44th annual global healthcare conference on monday, june 12, 2023 at 8:00 am pt (11:00 am et) at the waldorf astoria monarch beach resort & club in dana point, ca. a live audio webcast of the presentation will be available on the investors section of the company's website at www.alnylam.co.
ALNY Ratings Summary
ALNY Quant Ranking